NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Historical Holders from Q4 2022 to Q1 2025

Symbol
NAMS on Nasdaq
CUSIP
N62509109
Type / Class
Equity / Ordinary Shares, nominal value EUR0.12 per share
Shares outstanding
110M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
98.6M
Holdings value
$2.53B
% of all portfolios
0.017%
Grand Portfolio weight change
+0.001%
Number of holders
131
Number of buys
82
Number of sells
-47
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $223M 10.9M RA Capital Management, L.P. Dec 31, 2024
VIKING GLOBAL INVESTORS LP 6.5% $143M 6.98M VIKING GLOBAL INVESTORS LP Dec 31, 2024

Institutional Holders of NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 3.17M $64.8M +$1.72M $20.47 10
2024 Q4 98.6M $2.53B +$570M $25.70 131
2024 Q3 77.1M $1.28B +$65.9M $16.60 102
2024 Q2 72M $1.38B -$7.86M $19.21 90
2024 Q1 72.2M $1.71B +$239M $23.65 76
2023 Q4 61.9M $691M -$381K $11.17 32
2023 Q3 50.2M $464M +$5.44M $9.25 35
2023 Q2 48.8M $581M +$184M $11.89 29
2023 Q1 33.3M $445M +$689K $13.26 20
2022 Q4 33.5M $362M +$362M $10.90 14